Synergy research: approaching a new generation of phytopharmaceuticals.

The longstanding, successful use of herbal drug combinations in traditional medicine makes it necessary to find a rationale for the pharmacological and therapeutic superiority of many of them in comparison to isolated single constituents. This review describes many examples of how modern molecular-biological methods (including new genomic technologies) can enable us to understand the various synergistic mechanisms underlying these effects. Synergistic effects can be produced if the constituents of an extract affect different targets or interact with one another in order to improve the solubility and thereby enhance the bioavailability of one or several substances of an extract. A special synergy effect can occur when antibiotics are combined with an agent that antagonizes bacterial resistance mechanisms. The verification of real synergy effects can be achieved through detailed pharmacological investigations and by means of controlled clinical studies performed in comparison with synthetic reference drugs. All the new ongoing projects aim at the development of a new generation of phytopharmaceuticals which can be used alone or in combination with synthetic drugs or antibiotics. This new generation of phytopharmaceuticals could lend phytotherapy a new legitimacy and enable their use to treat diseases which have hitherto been treated using synthetic drugs alone.

[1]  Y. Inoue,et al.  Green Tea Polyphenols Function as Prooxidants To Activate Oxidative-Stress-Responsive Transcription Factors in Yeasts , 2006, Applied and Environmental Microbiology.

[2]  Peter K. Gessner,et al.  A Straightforward Method for the Study of Drug Interactions: An Isobolographic Analysis Primer , 1988 .

[3]  T. Shimamura,et al.  Inhibition of Penicillinase by Epigallocatechin Gallate Resulting in Restoration of Antibacterial Activity of Penicillin against Penicillinase-Producing Staphylococcus aureus , 2002, Antimicrobial Agents and Chemotherapy.

[4]  L. Shao,et al.  Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants. , 2004, Microbial drug resistance.

[5]  J. Verhoef,et al.  The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. , 1998, The Journal of antimicrobial chemotherapy.

[6]  C. Kumana,et al.  Clinical role of beta-lactam/beta-lactamase inhibitor combinations. , 2003, Drugs.

[7]  T. Tsuchiya,et al.  Remarkable Synergies between Baicalein and Tetracycline, and Baicalein and β‐Lactams against Methicillin‐Resistant Staphylococcus aureus , 2005, Microbiology and immunology.

[8]  A. T. Sheldon.  Antibiotic Resistance: A Survival Strategy , 2005, American Society for Clinical Laboratory Science.

[9]  M. Nöldner,et al.  Rutin is Essential for the Antidepressant Activity of Hypericum perforatum Extracts in the Forced Swimming Test , 2002, Planta medica.

[10]  NICOLA TAMASSIA,et al.  NADPH oxidase of human dendritic cells: Role in Candida albicans killing and regulation by interferons, dectin‐1 and CD206 , 2007, European journal of immunology.

[11]  Peter Imming,et al.  Drugs, their targets and the nature and number of drug targets , 2007, Nature Reviews Drug Discovery.

[12]  P. Hrelia,et al.  Interaction of licorice on glycyrrhizin pharmacokinetics. , 1994, Environmental health perspectives.

[13]  U. Hafner,et al.  Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. , 1998, Pharmacopsychiatry.

[14]  T. Shimamura,et al.  [Appearance of antibacterial activity of oxacillin against methicillin resistant Staphylococcus aureus (MRSA) in the presence of catechin]. , 1995, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[15]  S. Shah,et al.  The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2' synthesis, and beta-lactamase production in Staphylococcus aureus. , 1998, The Journal of antimicrobial chemotherapy.

[16]  W. Mehnert,et al.  Pflanzliche Begleitstoffe — wertvolle Hilfsstoffe oder überflüssiger Ballast? , 2000 .

[17]  R. Polin,et al.  Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. , 1994, Journal of immunology.

[18]  T. Shimamura,et al.  Mechanism of Synergy between Epigallocatechin Gallate and β-Lactams against Methicillin-Resistant Staphylococcus aureus , 2001, Antimicrobial Agents and Chemotherapy.

[19]  H. Woelk.  Comparison of St John's wort and imipramine for treating depression: randomised controlled trial , 2000, BMJ : British Medical Journal.

[20]  L. Hall,et al.  Oxidative Stress Increases Susceptibility of Mycobacterium tuberculosis to Isoniazid , 2002, Antimicrobial Agents and Chemotherapy.

[21]  K. Chung,et al.  EFFECT OF A GINKGOLIDE MIXTURE (BN 52063) IN ANTAGONISING SKIN AND PLATELET RESPONSES TO PLATELET ACTIVATING FACTOR IN MAN , 1987, The Lancet.

[22]  H. Wagner.  Natural products chemistry and phytomedicine in the 21st century: New developments and challenges , 2005 .

[23]  I. Hindmarch.  A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour. , 1975, Arzneimittel-Forschung.

[24]  A. Rosato,et al.  The inhibition of Candida species by selected essential oils and their synergism with amphotericin B. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[25]  A. Nahrstedt,et al.  Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. , 1997, Pharmacopsychiatry.

[26]  J. Bouma,et al.  CERVICAL CARCINOMA IN YOUNGER PATIENTS , 1983, The Lancet.

[27]  Benjamin J. Whalley,et al.  Medicinal cannabis: is Δ9–tetrahydrocannabinol necessary for all its effects? , 2003 .

[28]  S. Loewe,et al.  Antagonisms and antagonists. , 1957, Pharmacological reviews.

[29]  H. Alakomi,et al.  Characterization of the action of selected essential oil components on gram-negative bacteria , 1998 .

[30]  M C Berenbaum,et al.  Criteria for analyzing interactions between biologically active agents. , 1981, Advances in cancer research.

[31]  K. Lundstrom,et al.  Neurochemical studies with St. John's wort in vitro. , 2001, Pharmacopsychiatry.

[32]  Shiew-Mei Huang,et al.  The interaction between St John's wort and an oral contraceptive , 2003, Clinical pharmacology and therapeutics.

[33]  R. Hartmann,et al.  Inhibition of 5 α-reductase and aromatase by PHL-00801 (Prostatonin®), a combination of PY102 (Pygeum africanum) and UR102 (Urtica dioica) extracts. , 1996, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[34]  M. Berenbaum.  What is synergy? , 1989, Pharmacological reviews.

[35]  J. Strandell,et al.  An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. , 2004, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[36]  Y. N. Singh,et al.  Kava: an overview. , 1992, Journal of ethnopharmacology.

[37]  W. Greco,et al.  The search for synergy: a critical review from a response surface perspective. , 1995, Pharmacological reviews.

[38]  A. Rosato,et al.  Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[39]  T. Tsuchiya,et al.  Mechanisms of Action of Corilagin and Tellimagrandin I That Remarkably Potentiate the Activity of β‐Lactams against Methicillin‐Resistant Staphylococcus aureus , 2004, Microbiology and immunology.

[40]  H. Wagner,et al.  Multitarget therapy--the future of treatment for more than just functional dyspepsia. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[41]  Jue-hee Lee,et al.  Berberine synergy with amphotericin B against disseminated candidiasis in mice. , 2005, Biological & pharmaceutical bulletin.

[42]  S. Krudsood,et al.  The future outlook of antimalarial drugs and recent work on the treatment of malaria. , 2002, Archives of medical research.

[43]  D. Bailey,et al.  Grapefruit juice-drug interactions. , 1998, British journal of clinical pharmacology.

[44]  N. Lall,et al.  Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[45]  Bernardo Morales,et al.  Principles: mechanisms and modeling of synergism in cellular responses. , 2005, Trends in pharmacological sciences.

[46]  G. Kaatz,et al.  Antibacterial and resistance modifying activity of Rosmarinus officinalis. , 2004, Phytochemistry.

[47]  Andrew G. Glen,et al.  APPL , 2001 .

[48]  Yongmoon Han.  Synergic effect of grape seed extract with amphotericin B against disseminated candidiasis due to Candida albicans. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[49]  R. Lüdtke,et al.  Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo‐controlled, double blind clinical trial , 2001, Phytotherapy research : PTR.

[50]  M C Berenbaum,et al.  Synergy, additivism and antagonism in immunosuppression. A critical review. , 1977, Clinical and experimental immunology.

[51]  M. Doble,et al.  Synergism between natural products and antibiotics against infectious diseases. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[52]  S. Loewe.  The problem of synergism and antagonism of combined drugs. , 1953, Arzneimittel-Forschung.

[53]  D. Durham,et al.  Baicalin synergy with beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other beta-lactam-resistant strains of S. aureus. , 2000, The Journal of pharmacy and pharmacology.

[54]  A. Nahrstedt,et al.  Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test. , 2000, Planta medica.

[55]  Berenbaum Mc.  What is synergy? , 1989, Pharmacological reviews.

[56]  R. Pertwee,et al.  Cannabinoids control spasticity and tremor in a multiple sclerosis model , 2000, Nature.

[57]  D. Wheatley.  Stress‐induced insomnia treated with kava and valerian: singly and in combination , 2001, Human psychopharmacology.

[58]  V. Schulz.  Johanniskrautextrakte vs. Synthetika: Neue Therapiestudien und Metaanalysen , 2003 .

[59]  T. Tsuchiya,et al.  Marked Potentiation of Activity of β-Lactams against Methicillin-Resistant Staphylococcus aureus by Corilagin , 2001, Antimicrobial Agents and Chemotherapy.

[60]  Volker Schulz Prof..  Johanniskrautextrakte vs. Synthetika: Neue Therapiestudien und Metaanalysen , 2003 .

[61]  E. Williamson,et al.  Synergy and other interactions in phytomedicines. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[62]  G. Born,et al.  Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal , 1962, Nature.

[63]  I. Kimura,et al.  Combined effects of Japanese‐Sino medicine ‘Kakkon‐to‐ka‐senkyu‐shin'i’ and its related combinations and component drugs on adjuvant‐induced inflammation in mice , 1992 .

[64]  I. Sassin,et al.  A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. , 2002, Zeitschrift fur Gastroenterologie.

[65]  V. Schulz.  Incidence and clinical relevance of the interactions and side effects of Hypericum preparations. , 2001, Phytomedicine.

[66]  K. Elango,et al.  Anticandidal activity of Santolina chamaecyparissus volatile oil. , 1997, Journal of ethnopharmacology.

[67]  G. Haas,et al.  Positive antibacterial co-action between hop (Humulus lupulus) constituents and selected antibiotics. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[68]  T. Koga,et al.  Increase of antioxidative potential of rat plasma by oral administration of proanthocyanidin-rich extract from grape seeds. , 1999, Journal of agricultural and food chemistry.

[69]  D. Atherton,et al.  A controlled trial of traditional Chinese medicinal plants in widespread non‐exudative atopic eczema , 1992, The British journal of dermatology.

[70]  A. Zuardi,et al.  Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. , 1982, Psychopharmacology.

[71]  K. Lewis,et al.  Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[72]  T. Ogihara,et al.  Improvement of accessory symptoms of hypertension by TSUMURA Orengedokuto Extract, a four herbal drugs containing Kampo-Medicine Granules for ethical use: a double-blind, placebo-controlled study. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[73]  D. Kennedy,et al.  Acute, dose‐dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand , 2002, Human psychopharmacology.

[74]  S. Gibbons,et al.  The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant , 2000, Phytotherapy research : PTR.

[75]  N. Satti,et al.  Herbal modulation of drug bioavailability: enhancement of rifampicin levels in plasma by herbal products and a flavonoid glycoside derived from Cuminum cyminum , 2007, Phytotherapy research : PTR.

[76]  D. Durham,et al.  Baicalin Synergy with β‐Lactam Antibiotics Against Methicillin‐resistant Staphylococcus aureus and Other β‐Lactam‐resistant Strains of S. aureus , 2000 .

[77]  H. Vogelsang,et al.  Therapie des aktiven Morbus Crohn mit dem Boswellia-serrata-Extrakt H 15 , 2001 .